Navigation Links
Insulet Reports Third Quarter 2008 Results
Date:11/6/2008

ecting the significant expansion of the Company's sales organization during this year. Total operating expenses in the third quarter of 2008 remained consistent with the level in the second quarter of 2008.

"We continued to make solid progress in strengthening Insulet's commercial and manufacturing operations in the third quarter. By successfully transitioning the majority of OmniPod manufacturing to China, we have been able to both increase production volumes and decrease per unit costs," said Duane DeSisto, Insulet's president and chief executive officer. "We broke through to positive gross profits in September and expect to further drive down production costs in the fourth quarter. Our operational infrastructure is positioned to deliver cost-effective growth of the innovative and easy-to- use OmniPod Insulin Management System."

For the nine months ended September 30, 2008, revenue increased 169% to $24.2 million from $9.0 million for the same period of 2007. Net loss for the first nine months of 2008 was $64.5 million, or $2.34 per share, compared to a net loss of $37.9 million, or $2.85 per share, for the same period in 2007. Operating expenses for first nine months of 2008 increased to $56.2 million from $27.7 million for the same period in 2007, primarily driven by increased sales and marketing expenses.

Revenue for the first nine months of 2008 was favorably impacted by $1.2 million due to a change in the Company's estimate of deferred revenue.

As of September 30, 2008, the Company's cash and cash equivalents totaled $74.1 million, compared to $94.6 million as of December 31, 2007.

Recent Highlights

-- Insulet achieved positive gross profit in the month of September, through significant growth in sales and improvement of manufacturing efficiencies.

-- The Company continued to execute on its strategy to transition the majority of OmniPod manufacturing to Flextronics in China, while successfully maintaining high-
'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (PRWEB) September 03, 2014 Recently, BambooIndustry.com, ... its new range of strand woven bamboo floors ... more clients and show its appreciation to the frequent ... products. , In addition to strand woven floors, ... clients, including hand scraped floors, click strand woven floors, ...
(Date:9/2/2014)... Atlanta, Ga. (PRWEB) September 02, 2014 ... hosted by, respectively, top-industry professionals Carey Lewis ... each person auditioning, seeking those who have the desire ... chosen for a callback, performers could be invited to ... SHINE convention. , Charlotte, NC – Saturday, Sept. 6, ...
(Date:9/2/2014)... 2014 The Wm. Jennings Bryan Dorn Veterans ... town hall meeting for Veterans and their families on September ... fair to provide Veterans with valuable healthcare and benefit information,” ... will provide a forum where we can gather important input ... outreach fair will be held 4:45 p.m. to 5:45 p.m. ...
(Date:9/2/2014)... In a large population-based study of randomly selected ... impairment (MCI) occurred twice more often in individuals ... strong association was only observed in middle-aged participants ... the association vanished. This study is published in ... The concept of MCI describes an intermediate state ...
(Date:9/2/2014)... Operators in the Community Services industry ... care and counsel for those in need. In 2014-15, ... derive $39.4 billion in revenue, which includes a combination ... five years through 2014-15, the subdivision is forecast to ... of 4.1% in 2014-15. , As the population ages ...
Breaking Medicine News(10 mins):Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3
... Using tiny gold particles embedded with dyes, researchers have ... of a living animal. These tools may allow doctors ... , Studded with antibody fragments called ScFv peptides that ... after their injection into a mouse. When illuminated with ...
... simple steps can help you cope , , SATURDAY, Dec. 22 ... of joy and celebration for many, it can trigger holiday ... to holiday blues, there are things you can do to ... Mood Disorders Program at the Jefferson Medical College of Thomas ...
... Kansas Hospital Offers Tips to Guard Against Influenza as ... ... While it may be too late to,purchase certain must-have gifts ... shot. The World Health Organization (WHO) and,National Respiratory and Enteric Virus ...
... PCYC ) today announced that it has received a ... for the company,s,new drug application (NDA) for Xcytrin(R) (motexafin ... (NSCLC) patients with brain,metastases. The NDA for use of ... filed with the FDA in April 2007., According ...
... indications than any other ... drug-eluting stent, ... announced today that its TAXUS(R) Liberte(TM),paclitaxel-eluting coronary stent system has received ... submitted,data showing the TAXUS Liberte stent has benefited diabetic patients with,coronary ...
... considered, protected, HARRISBURG, Pa., Dec. 21 To ... Joel,Ario today announced that the Insurance Department will hold ... the proposed consolidation of,Independence Blue Cross and Highmark Inc., ... would be protected in,any transaction of this type, so ...
Cached Medicine News:Health News:Gold nanoparticle probes may allow earlier cancer detection 2Health News:Gold nanoparticle probes may allow earlier cancer detection 3Health News:Maintaining Routine Can Chase Holiday Blues Away 2Health News:Attention Last-Minute Shoppers: Flu Shots Still Available 2Health News:Attention Last-Minute Shoppers: Flu Shots Still Available 3Health News:Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases 2Health News:Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases 3Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 2Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 3Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 4Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 5Health News:Insurance Department Will Hold Public Hearings on Proposed Consolidation of Highmark, Independence Blue Cross 2
(Date:9/2/2014)... 2, 2014 According to the ... Pre-packed, Analytical, Preparative), by Material (Metal, Glass, Plastic), by ... Forecast to 2018", published by MarketsandMarkets, the Chiral Chromatography ... is poised to grow at a CAGR of 5.2% ... Browse 90 market data tables and 15 ...
(Date:9/2/2014)... ALISO VIEJO, Calif. , Sept. 2, 2014  Avanir ... company management will present an overview of the company at ... York . , Presentation date: Tuesday September ... A live webcast and 30-day archive of ... About Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, ...
(Date:9/2/2014)... 2014  EMD Serono, Inc., a subsidiary of Merck ... that Drew Young has joined the company ... capacity, he will be responsible for leading the strategic ... future products.   Bringing more than 20 years ... efforts at pharmaceutical and biotech companies, Mr. Young comes ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4
... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Medicine Products: